The Fund aims to achieve capital appreciation by investing principally in equity securities of biotechnology companies and discovery research firms mainly located in the US.
AUM (million)
USD 1,810.00
FSM Risk Rating
10 - Highest Risk
Launch Date
24 Oct 2007
Launch Price
SGD 10.00
Historical Dividend
-
Dividend Yield (%)
-
Dividend Frequency
-
CPF Risk Classification
Higher Risk
Min. Initial Amount
SGD 100.00
Min. RSP Investment
SGD 100.00
RSP Special List
Yes
Annual Expense Ratio
1.81%
LEARN MORE
Latest NAV Price
Past 3 Months
SGD 59.12
SGD 4.46
More
Annualised Returns
1 WK 0.800%
1 MTH 2.630%
3 MTH 3.850%
6 MTH 4.230%
YTD 4.530%
1 YR 62.020%
2 YR 19.700%
3 YR 19.930%
5 YR 6.640%
10 YR 8.640%
Calendar Year Returns
2025 42.239%
2024 6.202%
2023 15.561%
2022 -13.135%
2021 -15.603%
Fund Historical Price
1Y High
60.59
16 Apr 2026
1Y Low
34.58
29 Jun 2025
3Y High
60.59
16 Apr 2026
3Y Low
30.15
09 Nov 2023
All Time High
60.59
16 Apr 2026
All Time Low
7.65
30 Nov 2008
Documents
Prospectus
20 Jan 2026
Semi-Annual Report
05 Mar 2026
Annual Report
07 Nov 2025
Product Highlights Sheet
05 Dec 2025
Fund Factsheet
24 May 2026
Funds Objective and Investment Information
Asset Class
Equity
Sector
Biotechnology
Geographical Allocation
Global
RSP Special List
Yes
MAS Registration
Recognised
Right to cancel
Yes
Pricing Basis
Forward Pricing
Min. Initial Amount
SGD 100.00
Min. Subsequent Investment
SGD 100.00
Min. Redemption Amount
SGD 100.00
Min. RSP Investment
SGD 100.00
Min. Holdings
SGD 1,000.00
Charges & Fees
Yes
Dividend
No
Fund Manager Information
Franklin Templeton is a global leader in asset management serving clients in over 170 countries. With over 70 years of active asset management experience, we continually strive to deliver better client outcomes through our focus on investment excellence and rigour.
We have specialised investment teams and extensive investment capabilities in equity, fixed income, multi-asset and alternatives. As pioneers in international investing, we have 600+ investment professionals on the ground across the globe to offer us global scale and local insights.
We take an active approach in everything you do. So when you invest with Franklin Templeton, you benefit from the strength and reach that come with size, and the insight that comes from experience.
READ MORE
Company
Franklin Templeton Investments
Address
7 Temasek Boulevard #38-03 Suntec Tower One Singapore 038987
Fund Top 10 Holdings (37.18% of Total Assets
16 Jun 2026)
All figures were extracted from the PDF, in the event of any discrepancies, please refer to the factsheet for confirmation.
Name
Weighting (%)
Sector
JAZZ PHARMACEUTICALS PLC
5.45
-
AMGEN INC
4.65
-
GILEAD SCIENCES INC
4.56
-
REGENERON PHARMACEUTICALS INC
4.09
-
VERTEX PHARMACEUTICALS INC
3.93
-
ARGENX SE
3.62
-
ASCENDIS PHARMA A/S
2.83
-
REVOLUTION MEDICINES INC
2.81
-
INSMED INC
2.78
-
PRAXIS PRECISION MEDICINES INC
2.46
-
Sector
Last Updated on 16 Jun 2026
All figures were extracted from the PDF, in the event of any discrepancies, please refer to the factsheet for confirmation.
Biotechnology
76.43%
Pharmaceuticals
16.32%
Cash & Cash Equivalents
3.94%
Health Care Services
2.06%
Life Sciences Tools & Services
0.87%
Managed Health Care
0.39%
Asset Management & Custody Banks
0.23%
Payment Method
Included under Cash Yes
Included under SRS Yes
Included under CPFIS-OA No
Included under CPFIS-SA No
Buy Processing Flow
Order Placement
18 Jun 2026
Order Transact
22 Jun 2026
Complete to Holdings
26 Jun 2026
Sell Processing Flow
Order Placement
18 Jun 2026
Order Transact
22 Jun 2026
Paid Out
01 Jul 2026
Risk Metric
3 YR Annualised Volatility
22.07%
3 YR Sharpe Ratio
0.83
1 YR Max Drawdown -8.57%
3 YR Max Drawdown -28.46%
Upcoming Fund Holidays MORE
Singapore
There are no upcoming fund holidays for this fund.
Fund Holiday
18Jun
Fund Holiday
Tools
Fund Ideas
Fund Returns
Fund RSP
Fund Selector
Recommended Fund
For further assistance, please call our hotline at 6557 2853 from:
8:30am to 10:30pm, (Mondays to Fridays except PH) and
8:30am to 12:30pm, (Saturdays except PH)
@ 2026. All Rights Reserved. Reg. No. 200000231R S&P ratings, @ 2026, S&P Capital IQ (and its affiliates, as applicable). All Rights Reserved. Copyright @ 2026, American Bankers Association CUSIP Database provided by the S&P Capital IQ LLC. All rights reserved. Copyright @ 2026, Market data provided by Cboe One Real-Time Quote, Morningstar Research Pte. Ltd. & Morningstar Real-Time Data Ltd. All Rights Reserved. Copyright @ 2026, HKEX market data provided by HKEX Information Services Ltd. All Rights Reserved.
We use cookies
If you close this message or continue to use this site, you will consent to the use of Cookies, unless you choose to disable them. Click on our Privacy Policy to understand more.